JEFFERY D EDWARDS

Allopathic & Osteopathic Physicians|Internal Medicine DALLAS, TX NPI 1518288604

General Payments — all program years on this page

$3,352.20

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 173
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $495.89 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $495.8922

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $705.1641
2019 $874.8852
2020 $163.099
2021 $144.457
2022 $486.9823
2023 $481.7519
2024 $495.8922

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078195489 Janssen Pharmaceuticals, Inc $27.71 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093949467 Alexion Pharmaceuticals, Inc. $20.24 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103677675 ABBVIE INC. $27.93 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103677677 ABBVIE INC. $27.23 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103677679 ABBVIE INC. $29.84 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103677681 ABBVIE INC. $29.15 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103677683 ABBVIE INC. $25.57 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103677685 ABBVIE INC. $25.64 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113898971 Paratek Pharmaceuticals, Inc. $15.24 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118041004 Boehringer Ingelheim Pharmaceuticals, Inc. $14.79 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133763987 Gilead Sciences, Inc. $21.30 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133763989 Gilead Sciences, Inc. $18.56 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133763991 Gilead Sciences, Inc. $24.71 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133763993 Gilead Sciences, Inc. $21.74 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133763995 Gilead Sciences, Inc. $20.64 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133763997 Gilead Sciences, Inc. $22.41 12/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141778881 Merck Sharp & Dohme LLC $20.25 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141778883 Merck Sharp & Dohme LLC $18.90 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153567896 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.12 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154332752 Shionogi Inc $22.14 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154332782 Shionogi Inc $19.71 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154332816 Shionogi Inc $21.07 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.